Skip to main content
Oliver Medzihradsky, MD, Internal Medicine, South Lake Tahoe, CA

OliverFelixMedzihradskyMD

Internal Medicine South Lake Tahoe, CA

Assistant Professor, Medicine, University of California, San Francisco, School of

Are you Dr. Medzihradsky?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 43 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    2170 South Ave
    South Lake Tahoe, CA 96150
    Phone+1 530-542-3000
    Fax+1 530-541-8723

Summary

  • Dr. Oliver Medzihradsky, MD is an internist in South Lake Tahoe, California. He is currently licensed to practice medicine in California, Nevada, and North Carolina. He is affiliated with Kaiser Permanente San Francisco Medical Center and is an Assistant Professor at University of California.

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Pediatric Infectious Diseases, 2008 - 2011
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine/Pediatrics, 1999 - 2005
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2025
  • NV State Medical License
    NV State Medical License 2005 - 2025
  • NC State Medical License
    NC State Medical License 2002 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Infectious Diseases

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Vaccine Maker Eyes the Nose for First Covid Clinical Trial
    Vaccine Maker Eyes the Nose for First Covid Clinical TrialMarch 16th, 2021